Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucose | 25 | 2020 | 177 | 4.190 |
Why?
|
Iron | 14 | 2020 | 117 | 4.090 |
Why?
|
Insulin Resistance | 17 | 2018 | 460 | 3.490 |
Why?
|
Adipocytes | 9 | 2019 | 79 | 2.870 |
Why?
|
Hemochromatosis | 9 | 2015 | 70 | 2.850 |
Why?
|
Liver | 12 | 2019 | 486 | 2.440 |
Why?
|
Iron, Dietary | 5 | 2019 | 13 | 2.100 |
Why?
|
Hexosamines | 8 | 2020 | 9 | 2.000 |
Why?
|
Mice | 45 | 2020 | 2524 | 1.760 |
Why?
|
Insulin | 18 | 2018 | 368 | 1.750 |
Why?
|
Insulin-Secreting Cells | 6 | 2013 | 53 | 1.620 |
Why?
|
Acetylglucosamine | 5 | 2011 | 5 | 1.570 |
Why?
|
Leptin | 5 | 2019 | 69 | 1.450 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2015 | 1428 | 1.420 |
Why?
|
Adipose Tissue | 8 | 2018 | 345 | 1.400 |
Why?
|
Animals | 48 | 2020 | 7694 | 1.270 |
Why?
|
Mice, Inbred C57BL | 20 | 2019 | 773 | 1.270 |
Why?
|
Muscle, Skeletal | 15 | 2018 | 514 | 1.240 |
Why?
|
Iron Overload | 3 | 2013 | 38 | 1.230 |
Why?
|
N-Acetylglucosaminyltransferases | 4 | 2008 | 6 | 1.180 |
Why?
|
Altitude | 4 | 2015 | 6 | 1.070 |
Why?
|
Signal Transduction | 10 | 2019 | 701 | 1.050 |
Why?
|
Protein Processing, Post-Translational | 4 | 2014 | 78 | 1.020 |
Why?
|
Blood Glucose | 9 | 2018 | 496 | 1.000 |
Why?
|
Models, Biological | 2 | 2019 | 397 | 0.930 |
Why?
|
Dietary Supplements | 4 | 2015 | 184 | 0.920 |
Why?
|
Gene Expression Regulation | 8 | 2020 | 502 | 0.900 |
Why?
|
Homeostasis | 3 | 2015 | 133 | 0.870 |
Why?
|
Oxygen | 3 | 2015 | 142 | 0.870 |
Why?
|
Ferritins | 4 | 2018 | 48 | 0.860 |
Why?
|
Gluconeogenesis | 4 | 2016 | 5 | 0.840 |
Why?
|
Diabetes Mellitus | 4 | 2014 | 410 | 0.830 |
Why?
|
Mice, Transgenic | 16 | 2020 | 261 | 0.800 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2019 | 19 | 0.800 |
Why?
|
Manganese | 2 | 2013 | 10 | 0.750 |
Why?
|
Adaptation, Physiological | 4 | 2015 | 55 | 0.750 |
Why?
|
Muscle Proteins | 6 | 2014 | 59 | 0.730 |
Why?
|
AMP-Activated Protein Kinases | 4 | 2014 | 38 | 0.690 |
Why?
|
Circadian Rhythm | 3 | 2014 | 44 | 0.670 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 81 | 0.670 |
Why?
|
Down-Regulation | 2 | 2019 | 144 | 0.660 |
Why?
|
Transferrin | 1 | 2018 | 33 | 0.650 |
Why?
|
Obesity | 7 | 2020 | 1164 | 0.630 |
Why?
|
Humans | 41 | 2020 | 32297 | 0.630 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2013 | 54 | 0.630 |
Why?
|
Glycogen Synthase | 4 | 2008 | 4 | 0.620 |
Why?
|
Male | 30 | 2020 | 19488 | 0.620 |
Why?
|
Energy Metabolism | 4 | 2015 | 147 | 0.610 |
Why?
|
Glucose Intolerance | 5 | 2015 | 47 | 0.600 |
Why?
|
Adiponectin | 4 | 2013 | 104 | 0.600 |
Why?
|
Fatty Acids | 5 | 2015 | 97 | 0.590 |
Why?
|
Phlebotomy | 2 | 2014 | 17 | 0.580 |
Why?
|
Protein-Serine-Threonine Kinases | 5 | 2013 | 50 | 0.570 |
Why?
|
Acclimatization | 2 | 2014 | 4 | 0.540 |
Why?
|
Hyperglycemia | 3 | 2018 | 84 | 0.530 |
Why?
|
Asian Continental Ancestry Group | 2 | 2014 | 111 | 0.520 |
Why?
|
Eating | 2 | 2015 | 75 | 0.520 |
Why?
|
Disease Models, Animal | 9 | 2020 | 1040 | 0.510 |
Why?
|
Glycosylation | 6 | 2019 | 15 | 0.500 |
Why?
|
Heme | 1 | 2014 | 61 | 0.480 |
Why?
|
3T3-L1 Cells | 4 | 2019 | 11 | 0.480 |
Why?
|
Polycythemia | 2 | 2014 | 2 | 0.460 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2014 | 59 | 0.450 |
Why?
|
Female | 25 | 2020 | 20126 | 0.450 |
Why?
|
Dietary Fats | 4 | 2012 | 110 | 0.450 |
Why?
|
Mice, Knockout | 11 | 2015 | 449 | 0.450 |
Why?
|
Cooperative Behavior | 2 | 2012 | 80 | 0.430 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2012 | 13 | 0.430 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 23 | 0.430 |
Why?
|
Membrane Proteins | 6 | 2014 | 260 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2009 | 70 | 0.420 |
Why?
|
Phosphorylation | 8 | 2014 | 234 | 0.400 |
Why?
|
Muscle Strength | 2 | 2011 | 157 | 0.400 |
Why?
|
Lipid Metabolism | 4 | 2013 | 103 | 0.390 |
Why?
|
Aging | 3 | 2020 | 953 | 0.380 |
Why?
|
Food | 2 | 2008 | 43 | 0.380 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 264 | 0.370 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 112 | 0.370 |
Why?
|
Iron Chelating Agents | 1 | 2010 | 8 | 0.360 |
Why?
|
Glucose Tolerance Test | 5 | 2018 | 126 | 0.350 |
Why?
|
Cell Line | 4 | 2018 | 462 | 0.340 |
Why?
|
Athletic Performance | 1 | 2009 | 12 | 0.330 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2018 | 1092 | 0.330 |
Why?
|
PPAR alpha | 3 | 2015 | 29 | 0.330 |
Why?
|
Oligosaccharides | 1 | 2008 | 4 | 0.330 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 4 | 0.330 |
Why?
|
Middle Aged | 13 | 2020 | 11949 | 0.330 |
Why?
|
RNA, Messenger | 5 | 2014 | 534 | 0.330 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 46 | 0.320 |
Why?
|
Monosaccharide Transport Proteins | 3 | 2004 | 8 | 0.320 |
Why?
|
Mitochondria, Liver | 1 | 2008 | 7 | 0.320 |
Why?
|
Resistance Training | 1 | 2009 | 80 | 0.310 |
Why?
|
Menopause | 1 | 2009 | 92 | 0.310 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 1 | 2007 | 2 | 0.310 |
Why?
|
Adult | 11 | 2020 | 9467 | 0.310 |
Why?
|
Anemia, Sickle Cell | 2 | 2020 | 43 | 0.300 |
Why?
|
Genotype | 3 | 2014 | 742 | 0.300 |
Why?
|
Glucosamine | 3 | 2019 | 7 | 0.300 |
Why?
|
Islets of Langerhans | 3 | 2007 | 76 | 0.300 |
Why?
|
Hep G2 Cells | 2 | 2019 | 26 | 0.300 |
Why?
|
Endothelial Cells | 2 | 2009 | 187 | 0.300 |
Why?
|
Parathyroid Neoplasms | 1 | 2007 | 7 | 0.300 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 213 | 0.300 |
Why?
|
Proteins | 2 | 2010 | 150 | 0.300 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 82 | 0.300 |
Why?
|
Cells, Cultured | 6 | 2012 | 846 | 0.300 |
Why?
|
Parathyroidectomy | 1 | 2007 | 15 | 0.300 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 53 | 0.290 |
Why?
|
Adenoma | 1 | 2007 | 39 | 0.290 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 17 | 0.290 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 144 | 0.290 |
Why?
|
Ultrasonography, Interventional | 1 | 2007 | 53 | 0.290 |
Why?
|
Transcription Factors | 5 | 2014 | 181 | 0.280 |
Why?
|
Mitochondria, Muscle | 3 | 2012 | 18 | 0.270 |
Why?
|
Oxidative Stress | 4 | 2013 | 230 | 0.270 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 1133 | 0.260 |
Why?
|
Tibet | 3 | 2015 | 3 | 0.260 |
Why?
|
Enzyme Activation | 4 | 2013 | 135 | 0.250 |
Why?
|
Oxygen Consumption | 3 | 2010 | 150 | 0.250 |
Why?
|
Gene Expression | 5 | 2014 | 345 | 0.250 |
Why?
|
Forkhead Transcription Factors | 3 | 2014 | 27 | 0.240 |
Why?
|
Streptozocin | 1 | 2004 | 8 | 0.240 |
Why?
|
Haplotypes | 2 | 2015 | 224 | 0.230 |
Why?
|
Oxidation-Reduction | 6 | 2018 | 268 | 0.230 |
Why?
|
Alleles | 2 | 2015 | 252 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 105 | 0.220 |
Why?
|
Receptor, Insulin | 3 | 2009 | 10 | 0.220 |
Why?
|
Gene Deletion | 3 | 2012 | 66 | 0.220 |
Why?
|
Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 1 | 0.210 |
Why?
|
Superoxide Dismutase | 3 | 2013 | 44 | 0.210 |
Why?
|
Apoptosis | 1 | 2004 | 368 | 0.210 |
Why?
|
Procollagen-Proline Dioxygenase | 2 | 2012 | 2 | 0.210 |
Why?
|
Myocardium | 3 | 2013 | 196 | 0.200 |
Why?
|
Mitochondria, Heart | 2 | 2013 | 17 | 0.200 |
Why?
|
Up-Regulation | 1 | 2002 | 196 | 0.200 |
Why?
|
Pyruvate Dehydrogenase Complex | 2 | 2012 | 18 | 0.200 |
Why?
|
Mutation | 2 | 2015 | 503 | 0.200 |
Why?
|
Transcription, Genetic | 2 | 2020 | 143 | 0.190 |
Why?
|
Prevalence | 2 | 2014 | 986 | 0.190 |
Why?
|
Lipid Peroxidation | 2 | 2013 | 32 | 0.190 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 326 | 0.190 |
Why?
|
Trans-Activators | 2 | 2013 | 46 | 0.190 |
Why?
|
Overweight | 2 | 2015 | 270 | 0.180 |
Why?
|
Metformin | 1 | 2020 | 22 | 0.180 |
Why?
|
Hypoglycemic Agents | 2 | 2020 | 188 | 0.180 |
Why?
|
Time Factors | 5 | 2020 | 2181 | 0.180 |
Why?
|
Mesangial Cells | 1 | 2020 | 10 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 28 | 0.180 |
Why?
|
Animal Feed | 1 | 2019 | 16 | 0.180 |
Why?
|
Kidney Tubules, Proximal | 1 | 2020 | 41 | 0.170 |
Why?
|
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 3 | 2004 | 3 | 0.170 |
Why?
|
Fructose | 1 | 2019 | 11 | 0.170 |
Why?
|
Disease Progression | 2 | 2019 | 618 | 0.170 |
Why?
|
Triglycerides | 5 | 2015 | 230 | 0.170 |
Why?
|
Cognition | 2 | 2020 | 551 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2014 | 158 | 0.170 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 77 | 0.160 |
Why?
|
Phenotype | 3 | 2015 | 656 | 0.160 |
Why?
|
Cohort Studies | 3 | 2018 | 1832 | 0.160 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 117 | 0.160 |
Why?
|
Selection, Genetic | 2 | 2015 | 8 | 0.160 |
Why?
|
Blood Pressure | 3 | 2013 | 859 | 0.160 |
Why?
|
Diabetic Nephropathies | 1 | 2020 | 225 | 0.160 |
Why?
|
Fatty Acids, Nonesterified | 3 | 2009 | 10 | 0.150 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 22 | 0.150 |
Why?
|
Cell Line, Tumor | 3 | 2008 | 736 | 0.150 |
Why?
|
Rats | 5 | 2020 | 1675 | 0.150 |
Why?
|
Young Adult | 4 | 2018 | 2626 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 14 | 0.150 |
Why?
|
Pyruvic Acid | 1 | 2016 | 6 | 0.140 |
Why?
|
Adenosine Triphosphate | 2 | 2013 | 53 | 0.140 |
Why?
|
Risk Factors | 3 | 2014 | 3876 | 0.140 |
Why?
|
Hypoglycemia | 1 | 2016 | 46 | 0.130 |
Why?
|
Response Elements | 1 | 2015 | 16 | 0.130 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 52 | 0.130 |
Why?
|
Glucose Transporter Type 4 | 3 | 2004 | 9 | 0.130 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 10 | 0.130 |
Why?
|
Myositis | 1 | 2015 | 10 | 0.130 |
Why?
|
Ceramides | 1 | 2015 | 10 | 0.130 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2015 | 16 | 0.130 |
Why?
|
Blotting, Western | 2 | 2013 | 305 | 0.130 |
Why?
|
Lactic Acid | 1 | 2015 | 53 | 0.130 |
Why?
|
Motor Activity | 2 | 2015 | 327 | 0.120 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 9 | 0.120 |
Why?
|
Cold Temperature | 1 | 2015 | 49 | 0.120 |
Why?
|
Acetylcysteine | 1 | 2014 | 12 | 0.120 |
Why?
|
Amino Acids, Essential | 1 | 2014 | 1 | 0.120 |
Why?
|
Leucine-tRNA Ligase | 1 | 2014 | 1 | 0.120 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2014 | 6 | 0.120 |
Why?
|
Guanosine Triphosphate | 1 | 2014 | 8 | 0.120 |
Why?
|
Intra-Abdominal Fat | 1 | 2015 | 66 | 0.120 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 45 | 0.120 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 36 | 0.120 |
Why?
|
Mice, Obese | 2 | 2012 | 23 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 462 | 0.120 |
Why?
|
DNA Primers | 2 | 2011 | 90 | 0.120 |
Why?
|
European Continental Ancestry Group | 1 | 2018 | 1180 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 35 | 0.120 |
Why?
|
Antioxidants | 1 | 2014 | 114 | 0.120 |
Why?
|
Research Support as Topic | 2 | 2012 | 26 | 0.120 |
Why?
|
African Americans | 2 | 2018 | 1443 | 0.120 |
Why?
|
Frail Elderly | 1 | 2014 | 70 | 0.110 |
Why?
|
Mitochondria | 2 | 2012 | 188 | 0.110 |
Why?
|
Acetylation | 1 | 2013 | 16 | 0.110 |
Why?
|
Adenosine Monophosphate | 1 | 2013 | 8 | 0.110 |
Why?
|
Sarcopenia | 1 | 2014 | 60 | 0.110 |
Why?
|
Weight Gain | 2 | 2012 | 114 | 0.110 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2012 | 2 | 0.110 |
Why?
|
Glucose-6-Phosphatase | 1 | 2012 | 5 | 0.110 |
Why?
|
Myoblasts | 1 | 2013 | 38 | 0.110 |
Why?
|
Utah | 1 | 2012 | 15 | 0.110 |
Why?
|
Iron-Binding Proteins | 1 | 2012 | 5 | 0.110 |
Why?
|
Homozygote | 1 | 2012 | 60 | 0.110 |
Why?
|
Cation Transport Proteins | 1 | 2012 | 24 | 0.110 |
Why?
|
Ethnic Groups | 1 | 2015 | 480 | 0.110 |
Why?
|
Hypertension, Renal | 1 | 2012 | 29 | 0.110 |
Why?
|
Sodium Chloride, Dietary | 1 | 2012 | 29 | 0.110 |
Why?
|
PPAR gamma | 1 | 2012 | 47 | 0.110 |
Why?
|
Genetic Association Studies | 1 | 2012 | 147 | 0.100 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2011 | 2 | 0.100 |
Why?
|
Mass Screening | 1 | 2014 | 263 | 0.100 |
Why?
|
Glycolysis | 3 | 2009 | 20 | 0.100 |
Why?
|
Pilot Projects | 2 | 2012 | 536 | 0.100 |
Why?
|
Cyclophilins | 1 | 2010 | 2 | 0.090 |
Why?
|
Ribosomal Proteins | 1 | 2010 | 4 | 0.090 |
Why?
|
Body Mass Index | 1 | 2014 | 921 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2012 | 188 | 0.090 |
Why?
|
Liver Glycogen | 1 | 2010 | 4 | 0.090 |
Why?
|
Inflammation | 3 | 2020 | 542 | 0.090 |
Why?
|
Heart | 3 | 2013 | 182 | 0.090 |
Why?
|
Cell Differentiation | 1 | 2013 | 468 | 0.090 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 3 | 0.090 |
Why?
|
Diet | 1 | 2013 | 384 | 0.090 |
Why?
|
Thermogenesis | 1 | 2010 | 4 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2010 | 11 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 849 | 0.090 |
Why?
|
RNA | 1 | 2010 | 95 | 0.090 |
Why?
|
Regression Analysis | 1 | 2010 | 296 | 0.090 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2009 | 1 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 36 | 0.080 |
Why?
|
Enzyme Induction | 1 | 2008 | 33 | 0.080 |
Why?
|
Legislation, Food | 1 | 2008 | 1 | 0.080 |
Why?
|
Glycomics | 1 | 2008 | 1 | 0.080 |
Why?
|
Wheat Germ Agglutinins | 1 | 2008 | 1 | 0.080 |
Why?
|
Cytoplasm | 1 | 2008 | 34 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 54 | 0.080 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 133 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2009 | 75 | 0.080 |
Why?
|
Drug Industry | 1 | 2008 | 17 | 0.080 |
Why?
|
Aged | 5 | 2017 | 10398 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 48 | 0.080 |
Why?
|
Aconitate Hydratase | 1 | 2008 | 1 | 0.080 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 1 | 0.080 |
Why?
|
Electron Transport Complex IV | 1 | 2008 | 2 | 0.080 |
Why?
|
Adenoviridae | 1 | 2008 | 66 | 0.080 |
Why?
|
Succinate Dehydrogenase | 1 | 2008 | 3 | 0.080 |
Why?
|
Mitochondrial Proteins | 3 | 2014 | 67 | 0.080 |
Why?
|
Physical Fitness | 1 | 2009 | 127 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 154 | 0.080 |
Why?
|
Capillaries | 1 | 2008 | 24 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2008 | 125 | 0.080 |
Why?
|
Glycogen | 1 | 2007 | 3 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2008 | 112 | 0.080 |
Why?
|
Tissue Culture Techniques | 1 | 2008 | 41 | 0.080 |
Why?
|
Exercise Test | 1 | 2009 | 225 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2009 | 162 | 0.070 |
Why?
|
Thyroid Nodule | 1 | 2007 | 7 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2009 | 161 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 41 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2008 | 85 | 0.070 |
Why?
|
Organ Size | 2 | 2004 | 220 | 0.070 |
Why?
|
Cell Movement | 1 | 2008 | 171 | 0.070 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2007 | 23 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2007 | 55 | 0.070 |
Why?
|
Biomedical Research | 1 | 2008 | 169 | 0.070 |
Why?
|
Preoperative Care | 1 | 2007 | 116 | 0.070 |
Why?
|
Lipids | 1 | 2007 | 226 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 511 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2007 | 180 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 600 | 0.070 |
Why?
|
Exercise | 1 | 2011 | 655 | 0.060 |
Why?
|
Phosphofructokinase-2 | 1 | 2004 | 1 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2004 | 32 | 0.060 |
Why?
|
Adolescent | 2 | 2015 | 3571 | 0.060 |
Why?
|
Epididymis | 1 | 2004 | 29 | 0.060 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2003 | 3 | 0.060 |
Why?
|
Deoxyglucose | 1 | 2003 | 16 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2004 | 92 | 0.060 |
Why?
|
United States | 2 | 2012 | 3983 | 0.060 |
Why?
|
Fasting | 1 | 2003 | 97 | 0.060 |
Why?
|
3T3 Cells | 1 | 2003 | 14 | 0.060 |
Why?
|
Polysaccharides | 1 | 2002 | 13 | 0.050 |
Why?
|
Cytosol | 1 | 2002 | 27 | 0.050 |
Why?
|
Ventricular Myosins | 1 | 2002 | 1 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2004 | 602 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 103 | 0.050 |
Why?
|
Neoplasms | 1 | 2009 | 695 | 0.050 |
Why?
|
Hypertension | 1 | 2009 | 972 | 0.050 |
Why?
|
Metabolome | 2 | 2013 | 36 | 0.050 |
Why?
|
Age Factors | 1 | 2004 | 1204 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2007 | 770 | 0.050 |
Why?
|
Goblet Cells | 1 | 2020 | 5 | 0.050 |
Why?
|
Mucins | 1 | 2020 | 19 | 0.050 |
Why?
|
Child | 1 | 2007 | 2472 | 0.050 |
Why?
|
Cell Wall | 1 | 2019 | 6 | 0.040 |
Why?
|
Teichoic Acids | 1 | 2019 | 8 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2019 | 20 | 0.040 |
Why?
|
Hot Temperature | 1 | 2019 | 79 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 94 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 110 | 0.040 |
Why?
|
Palmitic Acid | 2 | 2009 | 12 | 0.040 |
Why?
|
Glucose Clamp Technique | 1 | 2018 | 12 | 0.040 |
Why?
|
Etoposide | 1 | 2017 | 34 | 0.040 |
Why?
|
Vincristine | 1 | 2017 | 18 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2017 | 37 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 176 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2020 | 245 | 0.040 |
Why?
|
Prednisone | 1 | 2017 | 62 | 0.040 |
Why?
|
Doxorubicin | 1 | 2017 | 79 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 4050 | 0.030 |
Why?
|
Bed Rest | 1 | 2015 | 2 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 20 | 0.030 |
Why?
|
Hemoglobins | 1 | 2015 | 49 | 0.030 |
Why?
|
Lagomorpha | 1 | 2015 | 1 | 0.030 |
Why?
|
Rest | 1 | 2015 | 53 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2014 | 7 | 0.030 |
Why?
|
Leucine | 1 | 2014 | 24 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 19 | 0.030 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2014 | 2 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 3 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 9 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 35 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
Reference Values | 1 | 2014 | 255 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 35 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2014 | 69 | 0.030 |
Why?
|
Cholesterol | 1 | 2015 | 251 | 0.030 |
Why?
|
Cardiac Output | 1 | 2013 | 36 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 34 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 560 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 17 | 0.030 |
Why?
|
Gene Order | 1 | 2012 | 6 | 0.030 |
Why?
|
Prostaglandin D2 | 1 | 2012 | 4 | 0.030 |
Why?
|
Gene Targeting | 1 | 2012 | 17 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2012 | 20 | 0.030 |
Why?
|
Diglycerides | 1 | 2012 | 4 | 0.030 |
Why?
|
Database Management Systems | 1 | 2012 | 12 | 0.030 |
Why?
|
Ion Channels | 1 | 2012 | 24 | 0.030 |
Why?
|
Rare Diseases | 1 | 2012 | 20 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2012 | 31 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2012 | 45 | 0.030 |
Why?
|
Renin | 1 | 2012 | 112 | 0.020 |
Why?
|
Arizona | 1 | 2011 | 8 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2011 | 12 | 0.020 |
Why?
|
Body Composition | 1 | 2012 | 384 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2011 | 83 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 696 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 60 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2010 | 61 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 877 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 3514 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 1522 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 37 | 0.020 |
Why?
|
Photoperiod | 1 | 2009 | 3 | 0.020 |
Why?
|
Period Circadian Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
alpha-MSH | 1 | 2009 | 2 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 44 | 0.020 |
Why?
|
Corticosterone | 1 | 2009 | 7 | 0.020 |
Why?
|
Hyperphagia | 1 | 2009 | 3 | 0.020 |
Why?
|
Hypothalamus | 1 | 2009 | 17 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 32 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2009 | 41 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2009 | 57 | 0.020 |
Why?
|
Triazenes | 1 | 2008 | 4 | 0.020 |
Why?
|
Amino Acids | 1 | 2009 | 49 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2008 | 7 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 9 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2008 | 6 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2009 | 55 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2010 | 470 | 0.020 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2008 | 10 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2009 | 62 | 0.020 |
Why?
|
Ribonucleotides | 1 | 2008 | 11 | 0.020 |
Why?
|
Vasodilation | 1 | 2009 | 93 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 35 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 37 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2009 | 121 | 0.020 |
Why?
|
Fibroblasts | 1 | 2009 | 118 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 61 | 0.020 |
Why?
|
Body Weight | 1 | 2010 | 311 | 0.020 |
Why?
|
Phosphorylase Kinase | 1 | 2007 | 1 | 0.020 |
Why?
|
Glycogen Phosphorylase | 1 | 2007 | 2 | 0.020 |
Why?
|
Apolipoprotein A-II | 1 | 2007 | 6 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 675 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2007 | 65 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2008 | 159 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2004 | 66 | 0.010 |
Why?
|
Collagen | 1 | 2004 | 228 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2002 | 8 | 0.010 |
Why?
|
Glucose Transporter Type 1 | 1 | 2002 | 7 | 0.010 |
Why?
|